Evidence map›Paper›PMID 32517042›Full record

ArticleInternational journal of environmental research and public health2020

Waiting Time between Breast Cancer Diagnosis and Treatment in Brazilian Women: An Analysis of Cases from 1998 to 2012.

Naidhia Alves Soares Ferreira, Jean Henri Maselli Schoueri, Isabel Cristina Esposito Sorpreso, Fernando Adami, Francisco Winter Dos Santos Figueiredo

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Determinants of Lack of Access to Treatment for Women Diagnosed with Breast Cancer in Brazil.International journal of environmental research and public health · 2022
    Article
  15. Initiatives to reduce the waiting time to initiate oncological treatment: a scoping literature review.Revista panamericana de salud publica = Pan American journal of public health · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Naidhia Alves Soares FerreiraLaboratory of Epidemiology and Data Analysis, University Center Health ABC - FMABC, Santo André 09060-870, Brazil.
Jean Henri Maselli SchoueriLaboratory of Epidemiology and Data Analysis, University Center Health ABC - FMABC, Santo André 09060-870, Brazil.
Isabel Cristina Esposito SorpresoFaculty of Medicine, University of São Paulo, São Paulo 05403-000, Brazil.ORCID 0000-0002-5475-5957
Fernando AdamiLaboratory of Epidemiology and Data Analysis, University Center Health ABC - FMABC, Santo André 09060-870, Brazil.
Francisco Winter Dos Santos FigueiredoLaboratory of Epidemiology and Data Analysis, University Center Health ABC - FMABC, Santo André 09060-870, Brazil.ORCID 0000-0002-9377-6443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brazilian law requires that treatment for breast cancer begin within 60 days of diagnosis. This waiting time is an indicator of accessibility to health services. The aim of this study was to analyze which factors are associated with waiting times between diagnosis and treatment of breast cancer in women in Brazil between 1998 and 2012. Information from Brazilian women diagnosed with breast cancer between 1998 and 2012 was collected through the Hospital Registry of Cancer (HRC), developed by the National Cancer Institute (INCA). We performed a secondary data analysis, and found that the majority of women (81.3%) waited for ≤60 days to start treatment after being diagnosed. Those referred by the public health system, aged ≥50 years, of nonwhite race, diagnosed at stage I or II, and with low levels of education waited longer for treatment to start. We observed that only 18.7% experienced a delay in starting treatment, which is a positive reflection of the quality of the care network for the diagnosis and treatment of breast cancer. We also observed inequalities in access to health services related to age, region of residence, stage of the disease, race, and origin of referral to the health service.

Indexed as

Waiting ListsBrazilBreast NeoplasmsFemaleHealth Services AccessibilityHumansReferral and ConsultationRegistriesSocioeconomic Factorsbreast cancereducation levels and cancerepidemiologypublic policiessocioeconomic status and cancerunified health system

Identifiers

PMID32517042
PMCPMC7312631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.